.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Chinese Patent Office
Baxter
McKesson
Cipla
Fuji
Cerilliant
McKinsey
Chubb
Medtronic

Generated: December 15, 2017

DrugPatentWatch Database Preview

Strides Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for STRIDES PHARMA, and what generic and branded alternatives to STRIDES PHARMA drugs are available?

STRIDES PHARMA has thirty-seven approved drugs.

There are two tentative approvals on STRIDES PHARMA drugs.

Summary for Strides Pharma

US Patents:0
Tradenames:30
Ingredients:30
NDAs:37
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Strides PharmaPROMETHAZINE HYDROCHLORIDEpromethazine hydrochlorideTABLET;ORAL209177-002Jun 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Strides PharmaPRAMIPEXOLE DIHYDROCHLORIDEpramipexole dihydrochlorideTABLET;ORAL202702-005Jun 3, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Strides PharmaTACROLIMUStacrolimusCAPSULE;ORAL090687-001Jul 22, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Strides PharmaPRAMIPEXOLE DIHYDROCHLORIDEpramipexole dihydrochlorideTABLET;ORAL202702-002Jun 3, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Strides PharmaTACROLIMUStacrolimusCAPSULE;ORAL090687-003Jul 22, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Strides PharmaPOTASSIUM CITRATEpotassium citrateTABLET, EXTENDED RELEASE;ORAL206813-003Sep 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Strides PharmaMYCOPHENOLATE MOFETILmycophenolate mofetilCAPSULE;ORAL090055-001Jun 10, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Strides PharmaMEMANTINE HYDROCHLORIDEmemantine hydrochlorideTABLET;ORAL202350-002May 23, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Strides PharmaACARBOSEacarboseTABLET;ORAL090912-001Jul 27, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Strides PharmaIBUPROFENibuprofenTABLET;ORAL078329-001Feb 5, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Chinese Patent Office
AstraZeneca
Johnson and Johnson
Chubb
Farmers Insurance
Teva
Cerilliant
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot